That wasn't a very nice comment @majestic001.
Joel's comments are spot on and the way you are commenting one would think it's related to completed human trials when in fact they are referring to models.
No one has a problem with continuing research but shareholders have been sitting on the edge of their seats for years for promised trial results which have failed to materialise.
I say bring on an announcement that will inspire the market so that the "uneducated shareholders " can get some relief
Ann: DEP irinotecan combination data presentation, page-8
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.003(3.09%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $12.72K | 127.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50204 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 64981 | 2 |
View Market Depth
| Last trade - 10.43am 18/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |